PAGE 2
Unequal access to COVID-19 vaccines and other COVID-19 technologies within
and across nations is undeniably an issue of racial injustice. Racism, racial discrimination,
xenophobia and related intolerance operate through both: (1) differential treatment of and
outcomes for individuals and groups on the grounds of their race, colour, descent, national
or ethnic origin; and (2) differential treatment of and outcomes for countries and
territories that were subject to prolonged exploitation and degradation during the colonial
era on the basis of racist theories and beliefs.
2
The Committee on the Elimination of Racial Discrimination (“CERD”) has
highlighted how the disproportionate impact of COVID-19 between and within countries
reproduces colonial hierarchies and represents the international community’s failure “to
redress the effects of racism rooted in slavery, colonialism and apartheid.”
3
Certain
“developed” nations and powerful transnational corporations based within their
jurisdictions have monopolized authority to determine “who is worth saving” — and this
hierarchical power cannot be unlinked from its colonial origins. Researchers have
observed that “[t]he map of winners and losers in the COVID-19 vaccination race appears
almost indistinguishable from the map of European colonialism”.
4
Additionally, the
relative financial burden of reaching the target vaccination rate of 70 per cent has been as
large as 71 times higher for low income countries compared to high income countries.
5
The uneven multilateral playing field has thus generated a “two-track pandemic”,
6
in
which certain countries are “plunged into multiple interlinked emergencies – a debt crisis,
a development crisis and a human rights crisis.”
7
The term “vaccine apartheid” aptly
describes the regime that has been in place for much of the pandemic.
In addition to curtailed access to COVID-19 vaccines, intellectual property
barriers have limited the supply of COVID-19 diagnostic technologies and therapeutic
treatments. Monopolies over the creation and supply of COVID-19 technologies have
exacerbated shortages for low-income nations, with States in a position to materially
transform the situation failing to do so.
CERD’s April 2022 statement, issued under its Early Warning and Urgent Action
Procedure, provides a comprehensive account of racially discriminatory COVID-19
outcomes within and between States. But CERD is not alone in identifying the unjust
nature of the current COVID-19 status quo. In fact, there is broad consensus throughout
the United Nations system that the current approach is untenable from a legal and moral
perspective. This consensus is captured in the findings and statements of, among others,
various Human Rights Council Special Procedures mandate holders,
8
Tedros Adhanom
2
I have made this point in several reports to the United Nations Human Rights Council and
General Assembly. See, e.g., A/HRC/41/54.
3
Committee on the Elimination of Racial Discrimination, “Statement on the lack of equitable
and non-discriminatory access to COVID-19 vaccines”, statement at the 106
th
session of CERD
(April 2022).
4
Tammam Aloudat, Dena Arjan Kirpalani and Meg Davis, “Decolonisation and Global
Health”, Geneva Graduate Institute, October 2021.
5
UNDP, Global Dashboard for Vaccine Equity. Available at https://data.undp.org/vaccine-
equity/
6
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, media
briefing on COVID-19, Geneva, 7 June 2021.
7
Michelle Bachelet, United Nations High Commissioner for Human Rights, statement to the
49th session of the Human Rights Council, Geneva, 11 March 2022.
8
See, for example, the statements included in footnote 1.